|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 72.22 USD | -7.22% |
|
+6.81% | +22.30% |
| 26/10 | Tempus AI Receives EU Certification for xR RNA Sequencing | MT |
| 24/10 | Tempus AI, Inc. Enters Into Multi-Year Agreement With Bristol Myers Squibb To License Multimodal Oncology Data | CI |
Company Valuation: Tempus AI, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 5,315 | 10,505 | 13,031 | - | - |
| Change | - | 97.64% | 24.04% | - | - |
| Enterprise Value (EV) 1 | 5,302 | 10,990 | 13,727 | 13,619 | 13,396 |
| Change | - | 107.29% | 24.9% | -0.79% | -1.64% |
| P/E | -5.42x | -41.9x | -51.8x | -53x | -99.1x |
| PBR | 94.1x | 20.8x | 25.9x | 21.9x | 16.6x |
| PEG | - | 0.5x | 46.82x | 23.19x | 2.1x |
| Capitalization / Revenue | 7.67x | 8.26x | 8.17x | 6.62x | 5.5x |
| EV / Revenue | 7.65x | 8.64x | 8.61x | 6.92x | 5.65x |
| EV / EBITDA | -50.6x | -1,488x | 211x | 93.6x | 50.2x |
| EV / EBIT | -37.3x | -233x | -1,218x | 364x | 81.9x |
| EV / FCF | -25.1x | -46x | 168x | 272x | 108x |
| FCF Yield | -3.98% | -2.18% | 0.59% | 0.37% | 0.93% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -6.23 | -1.41 | -1.394 | -1.363 | -0.7287 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 693.4 | 1,272 | 1,595 | 1,968 | 2,370 |
| EBITDA 1 | -104.7 | -7.385 | 65.1 | 145.6 | 266.8 |
| EBIT 1 | -142 | -47.19 | -11.27 | 37.4 | 163.7 |
| Net income 1 | -746.3 | -245 | -246.1 | -247.5 | -135 |
| Net Debt 1 | -13.71 | 484.5 | 695.6 | 587.9 | 365 |
| Reference price 2 | 33.76 | 59.05 | 72.22 | 72.22 | 72.22 |
| Nbr of stocks (in thousands) | 1,57,446 | 1,77,907 | 1,80,435 | - | - |
| Announcement Date | 24/02/25 | 24/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -51.79x | 8.61x | 210.84x | -.--% | 1.3TCr | ||
| 16.87x | 6.34x | 12.15x | 1.77% | 6.38TCr | ||
| 30.14x | 8.25x | 27.02x | 0.04% | 5.64TCr | ||
| 37.48x | 6.65x | 19.85x | 0.86% | 5.46TCr | ||
| 34.93x | 3.32x | 14.34x | -.--% | 4.41TCr | ||
| 48.85x | 5.63x | 30.81x | -.--% | 4.21TCr | ||
| -19.86x | 192.36x | -21.16x | -.--% | 4.1TCr | ||
| 47.33x | 8.41x | 28.18x | -.--% | 3.49TCr | ||
| 32x | 8.13x | 21.15x | 0.41% | 3.28TCr | ||
| -64.56x | 13.05x | -73.23x | -.--% | 2.47TCr | ||
| Average | 11.14x | 26.08x | 26.99x | 0.31% | 4.07TCr | |
| Weighted average by Cap. | 19.73x | 25.77x | 17.33x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- TEM Stock
- Valuation Tempus AI, Inc.
Select your edition
All financial news and data tailored to specific country editions
















